FEATURED ARTICLES
-
Emerging Gloveless Robotic Technologies In Aseptic Manufacturing For Personalized Cytotoxic Drugs
The blockbuster-model that was driving the pharmaceutical manufacturing industry in the last several decades has almost ended. Massive production, large batches, high speed lines have been designed to supply the patients with “multipurpose” small molecules drugs to cover the huge worldwide demand of health for the most common diseases. The next generation drugs will focus on the single patient and bespoke to cover the individual health demand. For instance, biotech products and large molecules are the most promising therapeutic means for treatment of different kinds of cancer. By Sergio Mauri, Manager, BU Integrated Projects, Fedegari Group
WHITE PAPERS & CASE STUDIES
-
Drastically Reduced Isolator Decontamination Cycles
With the use of catalytic aeration, M + P is able to reduce the duration of the aeration phase in isolators by about 50 %. The aeration phase is the most time consuming cycle during H2O2 decontamination. By Felix Henning, Optima Packaging Group GmbH
-
Emerging Fourth Generation Pharmaceutical Containment Technologies
Barrier technology has become overwhelmingly accepted as the basis for new aseptic processing facilities in 2013. The traditional clean room facilities of the 20th century are being rapidly replaced with advanced barrier based technology filling facilities. This technological evolution is dramatically reducing the risk of product contamination and risk of infection to patients. By Sterling Kline, RA IPS
-
A High Volume Process For Highly Potent (HP) Active Pharmaceutical Ingredients (APIs)
This case study demonstrates how a commercial manufacturing partnership between Alkermes Contract Pharma Services (Alkermes) and a large pharmaceutical company resulted in the establishment of a high volume process for Highly Potent (HP) Active Pharmaceutical Ingredients (APIs).
-
Alternatives to Traditional Fume Hoods: Ductless Enclosures And Fume Hoods
Safety is the primary purpose of any filtered enclosure or ventilated fume hood. In most situations, fume hoods remain the equipment of choice for ventilating hazardous airborne chemicals from the laboratory. By Gary Roepke, Senior Project Engineer, Labconco Corporation
-
Laboratory Fume Hood Conflict "Energy Savings" vs "Safe Containment"
Safety is the primary purpose of any laboratory hood. Facility managers and laboratory planners desire fume hoods that can conserve energy without compromising safety. Exhausting less air through a hood can result in substantial energy savings.
-
The XPert Nano Enclosure's Ability To Contain Nanoparticles Is NANOSAFE TESTEDâ„¢
NANOSAFE INC., an independent testing company, evaluated the XPert Nano Enclosure for its ability to contain nanoparticles.